Live Chat

True or False: The FDA Tested Lexapro Before Its Release to the Market

Answer: false. It’s a question many Americans get wrong. Most Americans believe that the Food and Drug Administration (FDA) independently tests potentially dangerous drugs, such as Lexapro (escitalopram). That’s simply not the case. Rather, the FDA relies upon the medical community and, most importantly, drug manufacturers to appropriately test and disclose the risks associated with new drugs.


Contrary to the belief of many consumers and the impression left by many Lexapro (escitalopram) advertisements, Lexapro is a dangerous drug. Not only has it been shown to notably increase the probability that newborn suffers from persistent pulmonary hypertension (PPHN), but also such cardiac birth defects as septal defects (holes in the wall of the heart), heart valve defects, coarctation of the aorta, pulmonary valve stenosis, and pulmonary atresia.


Has your child suffered from these birth defects? Did you take Lexapro (escitalopram) or another selective serotonin reuptake inhibitor (SSRI) during your pregnancy? If so, your families rights may have been violated. You deserve an analysis of your legal rights and opportunities for recovery. The dangerous drug experts and attorneys are prepared to help you. For a free consultation, call 1.866.545.8364 or email

Drug Litigation

True or False: The FDA Tested Lexapro Before Its Release to the Market